The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors.
Abstract Details
Predicting Overt Hepatic Encephalopathy for the Population with Cirrhosis
Tapper EB1,2. Hepatology. 2019 Jan 31. doi: 10.1002/hep.30533. [Epub ahead of print]
Author information
1 Division of Gastroenterology and Hepatology, University of Michigan.
2 Gastroenterology Section, VA Ann Arbor Healthcare System, Ann Arbor.
Abstract
Hepatic encephalopathy (HE) is associated with poor quality of life, sharply increased mortality, repeated hospitalizations, falls, and motor vehicle accidents. HE manifests with a dynamic spectrum of severity. Overt HE is clinically obvious disorientation, even coma. Although multiple strategies are available to characterize early stage HE, data are limited validating these methods in predicting overt HE, many are impractical in clinical practice, and test cutoffs relevant to the average patient clinicians manage are lacking. In order to accurately and efficiently classify the risk of overt HE in the population with cirrhosis, novel strategies may be needed. Herein, we review the potential competing strategies for the prediction of overt HE. We propose refining diagnostic cutoffs for tests designed to define early HE using overt HE as a gold standard and expanding prediction tools by using measures of components from the risk pathway for HE.